{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:37:05Z","timestamp":1791585425491,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmirs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Imaging and Radiation Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jmir.2020.01.007","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:00:13Z","timestamp":1585875613000},"page":"342-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cannabis and Radiation Therapy: A Scoping Review of Human Clinical\u00a0Trials"],"prefix":"10.1016","volume":"51","author":[{"given":"Tara","family":"Rosewall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Feuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jmir.2020.01.007_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"24","key":"10.1016\/j.jmir.2020.01.007_bib2","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jmir.2020.01.007_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3747\/co.23.3487","article-title":"A user\u2019s guide to cannabinoid therapies in oncology","volume":"23","author":"Maida","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jmir.2020.01.007_bib4","series-title":"Registered Dietitian Nutritionists\u2019 Awareness, attitudes, and experiences with cannabis use in oncology patients","author":"Rosenblum","year":"2018"},{"issue":"3","key":"10.1016\/j.jmir.2020.01.007_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3747\/co.25.3983","article-title":"Rates of cannabis use in patients with cancer","volume":"25","author":"Martell","year":"2018","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.007_bib6","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.3747\/co.25.3884","article-title":"Complementary and alternative medicine use in patients before and after a cancer diagnosis","volume":"25","author":"Buckner","year":"2018","journal-title":"Curr Oncol"},{"issue":"22","key":"10.1016\/j.jmir.2020.01.007_bib7","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1002\/cncr.30879","article-title":"Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jmir.2020.01.007_bib8","series-title":"Principles and practice of radiation oncology","first-page":"730","author":"Halperin","year":"2008"},{"issue":"18","key":"10.1016\/j.jmir.2020.01.007_bib9","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ejca.2007.09.010","article-title":"Medicinal cannabis in oncology","volume":"43","author":"Engels","year":"2007","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.jmir.2020.01.007_bib10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1200\/JCO.2017.76.1221","article-title":"Medical oncologists\u2019 beliefs, practices, and knowledge regarding marijuana used therapeutically: a nationally representative survey study","volume":"36","author":"Braun","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.007_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.21037\/apm.2018.06.04","article-title":"Cannabis in palliative care: current challenges and practical recommendations","volume":"7","author":"Cyr","year":"2018","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.007_bib12","first-page":"e3618","article-title":"False news of a Cannabis cancer cure","volume":"11","author":"Shi","year":"2019","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.jmir.2020.01.007_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmir.2020.01.007_bib14","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jmir.2020.01.007_bib15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.007_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2125.1974.tb00257.x","article-title":"A pilot study of orally administered \u03941-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus","volume":"1","author":"Davies","year":"1974","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jmir.2020.01.007_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0009-9260(82)80383-8","article-title":"Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting","volume":"33","author":"Lucraft","year":"1982","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.jmir.2020.01.007_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1148\/radiology.150.2.6318262","article-title":"Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy","volume":"150","author":"Ungerleider","year":"1984","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.007_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0009-9260(84)80088-4","article-title":"An initial evaluation of nabilone in the control of radiotherapy-induced nausea and vomiting","volume":"35","author":"Priestman","year":"1984","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jmir.2020.01.007_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0009-9260(87)80151-4","article-title":"A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea","volume":"38","author":"Priestman","year":"1987","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jmir.2020.01.007_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A pilot clinical study of \u0394 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme","volume":"95","author":"Guzman","year":"2006","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jmir.2020.01.007_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial","volume":"125","author":"C\u00f4t\u00e9","year":"2016","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"10.1016\/j.jmir.2020.01.007_bib23","first-page":"3517","article-title":"Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy","volume":"24","author":"Elliott","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmir.2020.01.007_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/2150132719831871","article-title":"Medical marijuana knowledge and attitudes: a survey of the california pharmacists association","volume":"10","author":"Szyliowicz","year":"2019","journal-title":"J Prim Care Community Health"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-0559","article-title":"Provider perspectives on use of medical marijuana in children with cancer","volume":"141","author":"Ananth","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jmir.2020.01.007_bib26","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.5688\/ajpe6296","article-title":"Pharmacy student knowledge, confidence and attitudes toward medical cannabis and curricular coverage","volume":"82","author":"Caligiuri","year":"2018","journal-title":"Am J Pharm Educ"},{"issue":"6","key":"10.1016\/j.jmir.2020.01.007_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hed.23035","article-title":"Late complications and long-term quality of life for survivors (> 5 years) with history of head and neck cancer","volume":"35","author":"Payakachat","year":"2013","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.jmir.2020.01.007_bib28","first-page":"716","article-title":"Minnesota pharmacists and medical cannabis: a survey of knowledge, concerns, and interest prior to program launch","volume":"41","author":"Hwang","year":"2016","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.jmir.2020.01.007_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/can.2018.0002","article-title":"A National Needs Assessment of Canadian nurse practitioners regarding cannabis for therapeutic purposes","volume":"3","author":"Balneaves","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"issue":"8","key":"10.1016\/j.jmir.2020.01.007_bib30","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2013recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jmir.2020.01.007_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.jmir.2020.01.007_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpainsymman.2014.05.018","article-title":"Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience","volume":"49","author":"Waissengrin","year":"2015","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jmir.2020.01.007_bib33","series-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","year":"2017"},{"issue":"9","key":"10.1016\/j.jmir.2020.01.007_bib34","first-page":"3029","article-title":"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"Turcott","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmir.2020.01.007_bib35","first-page":"2864384","article-title":"Medical cannabinoids for cancer cachexia: a systematic review and meta-analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"issue":"13","key":"10.1016\/j.jmir.2020.01.007_bib36","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ"},{"issue":"23","key":"10.1016\/j.jmir.2020.01.007_bib37","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmir.2020.01.007_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Schunemann","year":"2019","journal-title":"J Clin Epidemiol"}],"updated-by":[{"DOI":"10.1016\/j.jmir.2020.11.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Journal of Medical Imaging and Radiation Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865420300072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865420300072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:47:30Z","timestamp":1761850050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939865420300072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1939865420300072"],"URL":"https:\/\/doi.org\/10.1016\/j.jmir.2020.01.007","relation":{},"ISSN":["1939-8654"],"issn-type":[{"value":"1939-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis and Radiation Therapy: A Scoping Review of Human Clinical\u00a0Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Imaging and Radiation Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmir.2020.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.","name":"copyright","label":"Copyright"}]}}